Kathryn Winter
About
Kathryn Winter is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology.
According to data from OpenAlex, Kathryn Winter has authored 21 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Oncology. Recurrent topics in Kathryn Winter's work include Colorectal and Anal Carcinomas (7 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Gastric Cancer Management and Outcomes (5 papers). Kathryn Winter is often cited by papers focused on Colorectal and Anal Carcinomas (7 papers), Bladder and Urothelial Cancer Treatments (5 papers) and Gastric Cancer Management and Outcomes (5 papers). Kathryn Winter collaborates with scholars based in United States and Canada. Kathryn Winter's co-authors include Christopher G. Willett, W. Robert Lee, William U. Shipley, Donald S. Kaufman, Reuben S. Doggett, William Tester, Bryan Donnelly, Peter Venner, N.M. Heney and Lawrence D. True and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and International Journal of Radiation Oncology*Biology*Physics.
In The Last Decade
Kathryn Winter
20 papers receiving 1.4k citations
Peers
Kathryn Winter
Jeffrey Brindle United States
Jeremy Tey Singapore
Fernando Muñoz Italy
P. Bontemps France
D. Frohneberg Germany
Ganesh Bakshi India
Galal El‐Gazzaz United States
Leire Arbea Spain
Daphna Y. Spiegel United States
Ignacio Azinovic Spain
Citations per year, relative to Kathryn Winter Kathryn Winter (= 1×)
peers
Jeffrey Brindle
Countries citing papers authored by Kathryn Winter
Since
Specialization
Citations
This map shows the geographic impact of Kathryn Winter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Winter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Winter more than expected).
Fields of papers citing papers by Kathryn Winter
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Kathryn Winter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Winter. The network helps show where Kathryn Winter may publish in the future.
Co-authorship network of co-authors of Kathryn Winter
This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Winter. A scholar is included among the top collaborators of Kathryn Winter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Winter. Kathryn Winter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Suntharalingam, Mohan, Kathryn Winter, David H. Ilson, et al.. (2014). The initial report of RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery.. Journal of Clinical Oncology. 32(3_suppl). LBA6–LBA6.
2.
Michalski, Jeff M., Yan Yan, Deborah Watkins Bruner, et al.. (2013). Preliminary Toxicity Analysis of 3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy on the High-Dose Arm of the Radiation Therapy Oncology Group 0126 Prostate Cancer Trial. International Journal of Radiation Oncology*Biology*Physics. 87(5). 932–938.
3.
Jhingran, Anuja, Kathryn Winter, Lorraine Portelance, et al.. (2012). A Phase II Study of Intensity Modulated Radiation Therapy to the Pelvis for Postoperative Patients With Endometrial Carcinoma: Radiation Therapy Oncology Group Trial 0418. International Journal of Radiation Oncology*Biology*Physics. 84(1). e23–e28.
4.
Tucker, Susan L., Jeff M. Michalski, Walter Bosch, et al.. (2012). Use of fractional dose–volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06. Radiotherapy and Oncology. 104(1). 109–113.
5.
Tucker, Susan L., Lei Dong, Jeff M. Michalski, et al.. (2012). Do Intermediate Radiation Doses Contribute to Late Rectal Toxicity? An Analysis of Data From Radiation Therapy Oncology Group Protocol 94-06. International Journal of Radiation Oncology*Biology*Physics. 84(2). 390–395.
6.
Wong, Stuart J., Kathryn Winter, Neal J. Meropol, et al.. (2011). Radiation Therapy Oncology Group 0247: A Randomized Phase II Study of Neoadjuvant Capecitabine and Irinotecan or Capecitabine and Oxaliplatin With Concurrent Radiotherapy for Patients With Locally Advanced Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics. 82(4). 1367–1375.
7.
Kachnic, Lisa A., Kathryn Winter, Robert J. Myerson, et al.. (2011). Two-year outcomes of RTOG 0529: A phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal.. Journal of Clinical Oncology. 29(4_suppl). 368–368.
8.
Gunderson, Leonard L., Kathryn Winter, Jaffer A. Ajani, et al.. (2011). Long-term update of U.S. GI Intergroup RTOG 98-11 phase III trial for anal carcinoma: Comparison of concurrent chemoradiation with 5FU-mitomycin versus 5FU-cisplatin for disease-free and overall survival.. Journal of Clinical Oncology. 29(4_suppl). 367–367.
9.
Gunderson, Leonard L., Kathryn Winter, Jaffer A. Ajani, et al.. (2011). Long-term update of U.S. GI intergroup RTOG 98-11 phase III trial for anal carcinoma: Disease-free and overall survival with RT+5FU-mitomycin versus RT+5FU-cisplatin.. Journal of Clinical Oncology. 29(15_suppl). 4005–4005.
10.
Konski, André, Kathryn Winter, Bernard F. Cole, Kie‐Kian Ang, & Karen K. Fu. (2008). Quality‐adjusted survival analysis of Radiation Therapy Oncology Group (RTOG) 90‐03: Phase III randomized study comparing altered fractionation to standard fractionation radiotherapy for locally advanced head and neck squamous cell carcinoma. Head & Neck. 31(2). 207–212.
11.
Ajani, Jaffer A., Kathryn Winter, Leonard L. Gunderson, et al.. (2006). Intergroup RTOG 98–11: A phase III randomized study of 5-fluorouracil (5-FU), mitomycin, and radiotherapy versus 5-fluorouracil, cisplatin and radiotherapy in carcinoma of the anal canal. Journal of Clinical Oncology. 24(18_suppl). 4009–4009.
12.
Ajani, Jaffer A., Kathryn Winter, Gordon Okawara, et al.. (2006). Phase II Trial of Preoperative Chemoradiation in Patients With Localized Gastric Adenocarcinoma (RTOG 9904): Quality of Combined Modality Therapy and Pathologic Response. Journal of Clinical Oncology. 24(24). 3953–3958.
13.
Mohiuddin, Mohammed, Kathryn Winter, Edith P. Mitchell, et al.. (2006). Randomized Phase II Study of Neoadjuvant Combined-Modality Chemoradiation for Distal Rectal Cancer: Radiation Therapy Oncology Group Trial 0012. Journal of Clinical Oncology. 24(4). 650–655.
14.
Feigenberg, Steven J., W. Robert Lee, Michelle DeSilvio, et al.. (2005). Health-related quality of life in men receiving prostate brachytherapy on RTOG 98-05. International Journal of Radiation Oncology*Biology*Physics. 62(4). 956–964.
15.
Kaufman, Donald S., Kathryn Winter, William U. Shipley, et al.. (2005). Muscle-invading bladder cancer, RTOG Protocol 99–06: Initial report of a phase I/II trial of selective bladder-conservation employing TURBT, accelerated irradiation sensitized with cisplatin and paclitaxel followed by adjuvant cisplatin and gemcitabine chemotherapy. Journal of Clinical Oncology. 23(16_suppl). 4506–4506.
16.
Shipley, William U., Kathryn Winter, Donald S. Kaufman, et al.. (1999). Phase III Trial of Neoadjuvant Chemotherapy in Patients With Invasive Bladder Cancer Treated With Selective Bladder Preservation by Combined Radiation Therapy and Chemotherapy: Initial Results of Radiation Therapy Oncology Group 89-03. The Journal of Urology. 162(2). 623–624.
17.
Shipley, William U., Kathryn Winter, Donald S. Kaufman, et al.. (1999). 145 Initial results of RTOG 95-06: A phase I/II trial of transurethral surgery and fractionated twice-daily radiation with concurrent cisplatin and 5-fluorouracil followed either by selective bladder preservation or cystectomy for patients with muscle-invading bladder cancer. International Journal of Radiation Oncology*Biology*Physics. 45(3). 222–222.
18.
Shipley, William U., Kathryn Winter, Donald S. Kaufman, et al.. (1998). Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03.. Journal of Clinical Oncology. 16(11). 3576–3583.
19.
Shipley, William U., Kathryn Winter, Donald S. Kaufman, et al.. (1997). 41 : A Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy. International Journal of Radiation Oncology*Biology*Physics. 39(2). 155–155.
20.
Hollier, Larry H., Richard J. Fowl, Richard C. Pennell, et al.. (1986). Are seeded endothelial cells the origin of neointima on prosthetic vascular grafts?. Journal of Vascular Surgery. 3(1). 65–73.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jeffrey Brindle Breakdown of academic impact, for papers by Jeremy Tey Breakdown of academic impact, for papers by Fernando Muñoz Breakdown of academic impact, for papers by P. Bontemps Breakdown of academic impact, for papers by D. Frohneberg Breakdown of academic impact, for papers by Ganesh Bakshi Breakdown of academic impact, for papers by Galal El‐Gazzaz Breakdown of academic impact, for papers by Leire Arbea Breakdown of academic impact, for papers by Daphna Y. Spiegel Breakdown of academic impact, for papers by Ignacio Azinovic